8legs: Eli lilly and company

Your Followed Topics

#1 out of 2

health20h ago

BioSpace lists 11 companies hiring manufacturing professionals as 2026 starts, signaling sustained pharma production growth.
Johnson & Johnson plans to add 500 jobs at a new drug product manufacturing facility in Wilson, North Carolina.
AbbVie pledges $100 billion to U.S. R&D and capital investments, including manufacturing, over the next 10 years.
The article notes ongoing onshoring of manufacturing by major pharma firms, creating hundreds of opportunities.
Open roles span QA oversight, site training, purification techs, and manufacturing systems engineering.
Companies listed include AbbVie, ADMA Biologics, Amgen, BioMarin, Civica Rx, CSL, Eli Lilly, Legend Biotech, Novo Nordisk, Resilience, and Takeda.
The article lists locations across North Carolina, Illinois, Texas, Massachusetts, California, Ohio, Virginia, New Jersey, and more.
Johnson & Johnson’s Wilson project marks the company’s second major plant in Wilson County.
The piece underscores job opportunities across roles from API manufacturing to aseptic site training.

Vote 0

#2 out of 2

health12h ago

FDA orders label changes to Wegovy and Zepbound, removing suicide warnings after comprehensive review.
Agency found no increased suicide risk in 91 studies with more than 100,000 participants.
Saxenda also cited; label for older GLP-1 drug now cleared of suicide warning.
Company statements welcomed FDA's risk reassessment and plan to update safety information.
FDA compared risk across GLP-1 drugs to ensure consistent labeling.
Regulatory action followed reports of mood changes; FDA analyzed self-harm data in new users.
Regulators emphasized monitoring mood changes remains important.
Wegovy and Zepbound are GLP-1 medications; Ozempic and Mounjaro still carry different labeling.
FDA action aligns label language across GLP-1 drug portfolio.
Regulators consulted extensive clinical and real-world data in decision.

Vote 0

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.